BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 376097)

  • 21. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in sera of patients with juvenile rheumatoid arthritis.
    Moore TL; Osborn TG; Dorner RW
    Pediatr Res; 1986 Oct; 20(10):977-81. PubMed ID: 3095782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of human melanoma antigens in cell-free supernatants.
    Leong SP; Cooperband SR; Sutherland CM; Krementz ET; Deckers PJ
    J Surg Res; 1978 Apr; 24(4):245-52. PubMed ID: 347171
    [No Abstract]   [Full Text] [Related]  

  • 23. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
    Katano M; Saxton RE; Tsuchida T; Irie RF
    Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
    Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines.
    Dent PB; Liao SK; McCulloch PB; Stone BR; Singal DP
    Cancer; 1982 May; 49(10):2043-8. PubMed ID: 6176308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
    Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: immunopathological implications?
    Johnson PM
    Ann Rheum Dis; 1980 Dec; 39(6):586-8. PubMed ID: 7006526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
    Halliday WJ; Maluish A; Isbister WH
    Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
    Shiku H; Takahashi T; Oettgen HF
    J Exp Med; 1976 Oct; 144(4):873-81. PubMed ID: 978138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
    Carey TE; Takahashi T; Resnick LA; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3278-82. PubMed ID: 1067619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiimmunoglobulins of rheumatoid factor (RF) type in prediction of melanoma patients.
    Lochman I; Tvrdík J; Lochmanová A; Machálek J; Vrtná L; Kyselá T; Beska F; Repisták J; Konrád B; Cesaný P
    Neoplasma; 1986; 33(6):737-41. PubMed ID: 3808129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic diagnosis of toxoplasmosis with emphasis on the detection of Toxoplasma-specific immunoglobulin M antibodies.
    Fung JC; Clogston A; Swenson P; Kaplan M
    Am J Clin Pathol; 1985 Feb; 83(2):196-9. PubMed ID: 3881928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
    Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
    Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patients.
    Higuchi M; Robinson DS; Cailleau R; Irie RF; Morton DL
    Clin Exp Immunol; 1980 Jan; 39(1):90-6. PubMed ID: 7389200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheumatoid factors of immunoglobulin classes IgA, IgG and IgM: methods of determination and clinical value].
    Hermann E; Vogt P; Müller W
    Schweiz Med Wochenschr; 1986 Sep; 116(38):1290-7. PubMed ID: 3775335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis.
    Moore TL; Dorner RW; Zuckner J
    J Lab Clin Med; 1986 May; 107(5):465-70. PubMed ID: 3701193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rheumatoid factor activity as a disturbing factor in the serological diagnosis of specific IgM antibodies].
    Lindenschmidt EG
    Immun Infekt; 1984 Apr; 12(2):94-100. PubMed ID: 6398795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.
    Bampton JL; Cawston TE; Kyle MV; Hazleman BL
    Ann Rheum Dis; 1985 Jan; 44(1):13-9. PubMed ID: 3970590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.